Novomol

	Website: novomol.com
	Headquarters: Loerrach, , DE
	Company Type: New Startup (0-1M TTM Revenue)

Description
Sites

Formed in 2017, Novomol is a Germany-based life science start-up company focused on the continued advancement of our completely novel groundbreaking computational EDEN platform to discover new safe and efficacious drugs.

The EDEN platform, developed by Hans-Joachim Boehm, is a completely novel computational approach to drug discovery. Using either 2D structures of active compounds or the 3D protein structures of the target as input, EDEN generates a complex affinity fingerprint.

Site		Badges
	Novomol Floehbergweg 7 Loerrach, , 79541 Germany

Get started

If your organization has a Scientist.com marketplace, you can log in here to order products and services directly.

If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here.

To order products instantly, request access below.